Reduced vitamin D receptor (VDR) expression and plasma vitamin D levels are associated with aging‐related prostate lesions

No abstract is available for this paper.

• Publication year

  2018

• Venue

  The Prostate

• Publication date

  2018-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pros.23498PMID 29508414
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Basal Cells Show Increased Expression of Aromatase and Estrogen Receptor &agr; in Prostate Epithelial Lesions of Male Aging Rats

  2018cited by this paper
• Profile of cell proliferation and apoptosis activated by the intrinsic and extrinsic pathways in the prostate of aging rats

  2017cited by this paper
• Vitamin D and Chronic Diseases

  2017cited by this paper
• Low vitamin D status is associated with inflammation in patients with prostate cancer

  2017cited by this paper
• The vitamin D deficiency pandemic: Approaches for diagnosis, treatment and prevention

  2017cited by this paper
• Differential expression and regulation of vitamin D hydroxylases and inflammatory genes in prostate stroma and epithelium by 1,25-dihydroxyvitamin D in men with prostate cancer and an in vitro model.

  2015cited by this paper
• A prospective study of plasma 25-hydroxyvitamin D concentration and prostate cancer risk

  2015cited by this paper
• Changes in Estrogen Receptor ERβ (ESR2) Expression without Changes in the Estradiol Levels in the Prostate of Aging Rats

  2015cited by this paper
• Global cancer statistics, 2012

  2015cited by this paper
• Both serum 25-hydroxyvitamin D and calcium levels may increase the risk of incident prostate cancer in Caribbean men of African ancestry

  2015cited by this paper
• Positive association between circulating 25-hydroxyvitamin D levels and prostate cancer risk: new findings from an updated meta-analysis

  2014cited by this paper
• Early Growth Inhibition Is Followed by Increased Metastatic Disease with Vitamin D (Calcitriol) Treatment in the TRAMP Model of Prostate Cancer

  2014cited by this paper
• Circulating levels of 25-hydroxyvitamin D and prostate cancer prognosis.

  2013cited by this paper
• Phase II open label, multi‐center clinical trial of modulation of intermediate endpoint biomarkers by 1α‐hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin

  2013cited by this paper
• Vitamin D and aging.

  2013cited by this paper
• Distribution of Vitamin D Receptor and 1α-Hydroxylase in Male Mouse Reproductive Tract

  2013cited by this paper
• Dietary vitamin D₃ and 1,25-dihydroxyvitamin D₃ (calcitriol) exhibit equivalent anticancer activity in mouse xenograft models of breast and prostate cancer.

  2012cited by this paper
• Identification of the vitamin D receptor in various cells of the mouse kidney

  2012cited by this paper
• Serum 25-Hydroxy Vitamin D and Prostate Cancer Risk in a Large Nested Case–Control Study

  2011cited by this paper
• Vitamin D receptor protein expression in tumor tissue and prostate cancer progression.

  2011cited by this paper
• Vitamin D receptor (VDR)-mediated actions of 1α,25(OH)₂vitamin D₃: genomic and non-genomic mechanisms.

  2011cited by this paper
• Global cancer statistics

  2011cited by this paper
• Serum 25-OH vitamin D levels and risk of developing prostate cancer in older men

  2010cited by this paper
• Vitamin D receptor and vitamin D metabolizing enzymes are expressed in the human male reproductive tract.

  2010cited by this paper
• Plasma 25-hydroxyvitamin D and prostate cancer risk: the multiethnic cohort.

  2010cited by this paper
• Meta-analysis of longitudinal studies: Serum vitamin D and prostate cancer risk.

  2009cited by this paper
• Association between serum 25(OH)D and death from prostate cancer

  2009cited by this paper
• 5α-Androstane-3β,17β-diol (3β-diol), an estrogenic metabolite of 5α-dihydrotestosterone, is a potent modulator of estrogen receptor ERβ expression in the ventral prostrate of adult rats

  2007cited by this paper
• 5alpha-Androstane-3beta,17beta-diol (3beta-diol), an estrogenic metabolite of 5alpha-dihydrotestosterone, is a potent modulator of estrogen receptor ERbeta expression in the ventral prostrate of adult rats.

  2007cited by this paper
• Vitamin D Inhibits the Formation of Prostatic Intraepithelial Neoplasia in Nkx3.1; Pten Mutant Mice

  2006cited by this paper
• Prostatic intraepithelial neoplasia: an overview.

  2005cited by this paper
• Regulation of prostaglandin metabolism by calcitriol attenuates growth stimulation in prostate cancer cells.

  2005cited by this paper
• Circulating 25-hydroxyvitamin D levels indicative of vitamin D sufficiency: implications for establishing a new effective dietary intake recommendation for vitamin D.

  2005cited by this paper
• Androgen receptor signaling and vitamin D receptor action in prostate cancer cells

  2005cited by this paper
• Decreased retinoid X receptor-alpha protein expression in basal cells occurs in the early stage of human prostate cancer development.

  2004cited by this paper
• Regulation of androgen and vitamin d receptors by 1,25-dihydroxyvitamin D3 in human prostate epithelial and stromal cells.

  2003cited by this paper
• Vitamin D Inhibits G1 to S Progression in LNCaP Prostate Cancer Cells through p27Kip1 Stabilization and Cdk2 Mislocalization to the Cytoplasm*

  2003cited by this paper
• Vitamin D and androgen regulation of prostatic growth

  2003cited by this paper
• Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: a retrospective analysis.

  2003cited by this paper
• Expression patterns of vitamin D receptor in human prostate

  2001cited by this paper
• Reduced 1alpha-hydroxylase activity in human prostate cancer cells correlates with decreased susceptibility to 25-hydroxyvitamin D3-induced growth inhibition.

  2001cited by this paper
• 1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.

  2000cited by this paper
• 1α,25-Dihydroxyvitamin D3 Inhibits Prostate Cancer Cell Growth by Androgen-Dependent and Androgen-Independent Mechanisms.

  2000cited by this paper
• Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

  2000cited by this paper
• Localization of 1,25-dihydroxyvitamin D3 receptor (VDR) expression in human prostate.

  1998cited by this paper
• Age-dependent and lobe-specific spontaneous hyperplasia in the brown Norway rat prostate.

  1998cited by this paper
• The role of vitamin D in normal prostate growth and differentiation.

  1996cited by this paper
• P-glycoprotein-mediated acquired multidrug resistance of human lung cancer cells in vivo.

  1996cited by this paper
• Age and racial distribution of prostatic intraepithelial neoplasia.

  1996cited by this paper
• Antiproliferative effects of 1,25-dihydroxyvitamin D3 on primary cultures of human prostatic cells.

  1994cited by this paper
• Vitamin D and prostate cancer: 1,25 dihydroxyvitamin D3 receptors and actions in human prostate cancer cell lines.

  1993cited by this paper
• Is vitamin D deficiency a risk factor for prostate cancer? (Hypothesis).

  1990cited by this paper
• Distribution of soltriol [1,25(OH)2-vitamin D3] binding sites in male sex organs of the mouse: an autoradiographic study.

  1989cited by this paper

• Clinicopathological correlates of vitamin D receptor expression in prostate cancer: results of genomic analysis

  2025cites this paper
• Subchronic intake of arsenic at environmentally relevant concentrations causes histological lesions and oxidative stress in the prostate of adult Wistar rats.

  2024cites this paper
• Dietary Vitamin D Mitigates Coronavirus-Induced Lung Inflammation and Damage in Mice

  2023cites this paper
• Impact of VDR and RXR expression in non‐melanoma skin cancer pathogenesis

  2022cites this paper
• Bone Metastases of Diverse Primary Origin Frequently Express the VDR (Vitamin D Receptor) and CYP24A1

  2022cites this paper
• Vitamin D effects on androgen levels in men

  2021cites this paper
• Altered expression of the vitamin D metabolizing enzymes CYP27B1 and CYP24A1 under the context of prostate aging and pathologies.

  2021cites this paper
• A simple and sensitive method to detect vitamin D receptor expression in various disease models using stool samples

  2020cites this paper
• Tumor‐Associated Macrophages (TAM) are recruited to the aging prostate epithelial lesions and become intermingled with basal cells

  2020cites this paper
• Targeting Wistar rat as a model for studying benign, premalignant and malignant lesions of the prostate.

  2019cites this paper
• Oral 25-Hydroxycholecalciferol Acts as an Agonist in the Duodenum of Mice and as Modeled in Cultured Human HT-29 and Caco2 Cells

  2019cites this paper
• Vitamin D metabolites and their intestinal responses

  2019cites this paper
• Predicting biomedical relationships using the knowledge and graph embedding cascade model

  2019cites this paper
• Vitamin D3 mediated regulation of steroidogenesis mitigates testicular activity in an aged rat model.

  2019cites this paper
• Vitamin D status and its management for achieving optimal health benefits in the elderly

  2018cites this paper